...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.
【24h】

Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.

机译:通过使用非同位素溶液杂交检测聚合酶链反应扩增的原病毒DNA,评估1型人类免疫缺陷病毒的感染情况。

获取原文
           

摘要

A convenient assay combining solution hybridization and enzyme immunoassay for DNA-RNA hybrids (polymerase chain reaction-enzyme immunoassay [PCR-EIA]) was developed to detect human immunodeficiency virus type 1 (HIV-1) provirus amplified by the PCR and was compared with oligomer hybridization with 32P-labeled SK19. In PCR-EIA, a fragment of the HIV-1 gag gene from peripheral blood mononuclear cells was first amplified with primer pair SK38/SK39 or O1/O2. PCR-amplified material was reacted in solution with a biotinylated RNA probe. Biotinylated hybrids were measured in a microtiter-plate EIA with antibiotin antibody and a beta-D-galactosidase-conjugated monoclonal antibody to DNA-RNA hybrids. Ten copies of HIV-1 DNA could be detected by PCR-EIA by using two different sets of primers. HIV-1 DNA was detected in 104 of 108 peripheral blood mononuclear cell samples by using SK38/39 and oligomer hybridization, in 104 of 108 samples by using SK38/SK39 and PCR-EIA, and in 104 of 108 samples by using O1/O2 and PCR-EIA. HIV-1 provirus was detected in 107 of 108 samples by using a combination of two sets of primers. One sample from a seropositive patient was negative in all three PCR assays, and six samples gave discordant results between primer pairs. Six of the latter samples scored negative in a PCR for beta-globin but became positive when the sample was diluted before amplification. When applied to clinical samples, PCR-EIA generated results similar to those of an isotopic assay for detection of amplified DNA.
机译:开发了一种将溶液杂交和酶免疫分析相结合的简便测定方法,用于DNA-RNA杂交体(聚合酶链反应-酶免疫测定[PCR-EIA]),以检测通过PCR扩增的人免疫缺陷病毒1型(HIV-1)前病毒,并与之进行比较。寡聚体与32P标记的SK19杂交。在PCR-EIA中,首先用引物对SK38 / SK39或O1 / O2扩增来自外周血单核细胞的HIV-1 gag基因的片段。 PCR扩增的物质在溶液中与生物素化的RNA探针反应。在微量滴定板EIA中使用抗生物素抗体和针对DNA-RNA杂交体的β-D-半乳糖苷酶偶联单克隆抗体对生物素化的杂交体进行了测量。使用两组不同的引物,通过PCR-EIA可以检测到十份HIV-1 DNA。通过SK38 / 39和寡聚物杂交在108个外周血单核细胞样本中的104个样本中,通过使用SK38 / SK39和PCR-EIA在108个样本中的104个样本中以及使用O1 / O2在108个样本中的104个样本中检测到HIV-1 DNA和PCR-EIA。通过使用两组引物的组合,在108个样本中的107个样本中检测到HIV-1前病毒。血清阳性患者的一个样本在所有三个PCR分析中均为阴性,而六个样本在引物对之间给出的结果不一致。后一个样本中有六个在PCR中β-珠蛋白的得分为阴性,但在扩增前将其稀释后变为阳性。当应用于临床样品时,PCR-EIA产生的结果类似于用于检测扩增的DNA的同位素测定的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号